Reduced skeletal muscle oxidative capacity and impaired training adaptations in heart failure

Physiological Reports

Volumn 3, Issue 4, 2015, Pages

  Southern, William M ^a   Ryan, Terence E ^b   Kepple, Kirsten ^c   Murrow, Jonathan R ^a,c   Nilsson, Kent R ^a,c   McCully, Kevin K ^a  

^a UNIVERSITY OF GEORGIA   (United States)

^b EAST CAROLINA UNIVERSITY   (United States)

^c AUGUSTA UNIVERSITY   (United States)

Author keywords

Exercise training; Heart failure; Mitochondria; Near infrared spectroscopy; Skeletal muscle

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE; HEMOGLOBIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METFORMIN;

ADIPOSE TISSUE THICKNESS; ADULT; AGED; ANALYTICAL PARAMETERS; ARM BLOOD FLOW; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DYNAMOMETRY; ENDURANCE TRAINING; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HUMAN; MALE; METABOLIC CAPACITY; MITOCHONDRIAL BIOGENESIS; NEAR INFRARED SPECTROSCOPY; OXYGEN CONSUMPTION; QUESTIONNAIRE; SKELETAL MUSCLE OXIDATIVE CAPACITY;

EID: 85003534342     PISSN: None     EISSN: 2051817X     Source Type: Journal    
DOI: 10.14814/phy2.12353     Document Type: Article

References (64)

1. Abozguia, K., T. T. Phan, G. N. Shivu, A. R. Maher, I. Ahmed, A. Wagenmakers, et al. 2008. Reduced in vivo skeletal muscle oxygen consumption in patients with chronic heart failure — A study using Near Infrared Spectrophotometry (NIRS). Eur. J. Heart Fail. 10:652–657.
2. Ades, P. A., S. J. Keteyian, G. J. Balady, N. Houston-Miller, D. W. Kitzman, D. M. Mancini, et al. 2013. Cardiac Rehabilitation exercise and self-care for chronic heart failure. JACC Heart Fail. 1:540–547.
3. Anker, S. D., P. Ponikowski, S. Varney, T. P. Chua, A. L. Clark, K. M. Webb-Peploe, et al. 1997. Wasting as independent risk factor for mortality in chronic heart failure. Lancet 349:1050–1053.
4. Arnolda, L., J. Brosnan, B. Rajagopalan, and G. K. Radda. 1991. Skeletal muscle metabolism in heart failure in rats. Am. J. Physiol. 261:H434–H442.
5. Belardinelli, R., D. Georgiou, G. Cianci, and A. Purcaro. 1999. Randomized, controlled trial of long-term moderate exercise training in chronic heart failure: effects on functional capacity, quality of life, and clinical outcome. Circulation 99:1173–1182.
6. Braunstein, J. B., G. F. Anderson, G. Gerstenblith, W. Weller, M. Niefeld, R. Herbert, et al. 2003. Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure. J. Am. Coll. Cardiol. 42:1226–1233.
7. Buchheit, M., P. Ufland, B. Haydar, P. B. Laursen, and S. Ahmaidi. 2011. Reproducibility and sensitivity of muscle reoxygenation and oxygen uptake recovery kinetics following running exercise in the field. Clin. Physiol. Funct. Imaging 31:337–346.
8. Capllonch-Amer, G., M. Sbert-Roig, B. M. Galmes-Pascual, A. M. Proenza, I. Llado, M. Gianotti, et al. 2014. Estradiol stimulates mitochondrial biogenesis and adiponectin expression in skeletal muscle. J. Endocrinol. 221:391–403.
9. Cavalcanti-de-Albuquerque, J. P., I. C. Salvador, E. L. Martins, D. Jardim-Messeder, J. P. Werneck-de-Castro, A. Galina, et al. 2014. Role of estrogen on skeletal muscle mitochondrial function in ovariectomized rats: a time course study in different fiber types. J. Appl. Physiol. 116:779–789.
10. Chati, Z., F. Zannad, C. Jeandel, B. Lherbier, J.-M. Escanye, J. Robert, et al. 1996. Physical deconditioning may be a mechanism for the skeletal muscle energy phosphate metabolism abnormalities in chronic heart failure. Am. Heart J. 131:560–566.
11. Delp, M. D., C. Duan, J. P. Mattson, and T. I. Musch. 1997. Changes in skeletal muscle biochemistry and histology relative to fiber type in rats with heart failure. J. Appl. Physiol. (1985) 83:1291–1299.
12. van Deursen, V. M., R. Urso, C. Laroche, K. Damman, U. Dahlstrom, L. Tavazzi, et al. 2014. Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot Survey. Eur. J. Heart Fail. 16:103–111.
13. Drexler, H., D. Hayoz, T. Munzel, B. Hornig, H. Just, H. R. Brunner, et al. 1992a. Endothelial function in chronic congestive heart failure. Am. J. Cardiol. 69:1596–1601.
14. Drexler, H., U. Riede, T. Münzel, H. König, E. Funke, and H. Just. 1992b. Alterations of skeletal muscle in chronic heart failure. Circulation 85:1751–1759.
15. Duscha, B. D., W. E. Kraus, S. J. Keteyian, M. J. Sullivan, H. J. Green, F. H. Schachat, et al. 1999. Capillary density of skeletal muscle: a contributing mechanism for exercise intolerance in class II-III chronic heart failure independent of other peripheral alterations. J. Am. Coll. Cardiol. 33:1956–1963.
16. Franciosa, J. A., M. Park, and T. B. Levine. 1981. Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure. Am. J. Cardiol. 47:33–39.
17. Fulster, S., M. Tacke, A. Sandek, N. Ebner, C. Tschope, W. Doehner, et al. 2013. Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF). Eur. Heart J. 34:512–519.
18. Garnier, A., D. Fortin, C. Deloménie, I. Momken, V. Veksler, and R. Ventura-Clapier. 2003. Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles. J. Physiol. 551:491–501.
19. Gollnick, P. D., R. B. Armstrong, B. Saltin, C. W. T. Saubert, W. L. Sembrowich, and R. E. Shepherd. 1973. Effect of training on enzyme activity and fiber composition of human skeletal muscle. J. Appl. Physiol. 34:107–111.
20. Hamaoka, T., K. K. McCully, V. Quaresima, K. Yamamoto, and B. Chance. 2007. Near-infrared spectroscopy/imaging for monitoring muscle oxygenation and oxidative metabolism in healthy and diseased humans. J. Biomed. Opt. 12:062105-1–062105-16.
21. Hambrecht, R., J. Niebauer, E. Fiehn, B. K € alberer, B. Offner, K. Hauer, et al. 1995. Physical training in patients with stable chronic heart failure: Effects on cardiorespiratory fitness and ultrastructural abnormalities of leg muscles. J. Am. Coll. Cardiol. 25:1239–1249.
22. Haykowsky, M. J., P. H. Brubaker, T. M. Morgan, S. Kritchevsky, J. Eggebeen, and D. W. Kitzman. 2013. Impaired aerobic capacity and physical functional performance in older heart failure patients with preserved ejection fraction: role of lean body mass. J. Gerontol. A Biol. Sci. Med. Sci. 68:968–975.
23. Haykowsky, M. J., E. J. Kouba, P. H. Brubaker, B. J. Nicklas, J. Eggebeen, and D. W. Kitzman. 2014. Skeletal muscle composition and its relation to exercise intolerance in older patients with heart failure and preserved ejection fraction. Am. J. Cardiol. 113:1211–1216.
24. Henriksson, J. 1977. Training induced adaptation of skeletal muscle and metabolism during submaximal exercise. J. Physiol. 270:661–675.
25. Kent-Braun, J. A., and A. V. Ng. 2000. Skeletal muscle oxidative capacity in young and older women and men. J. Appl. Physiol. 89:1072–1078.
26. Keteyian, S. J. 2011. Exercise training in congestive heart failure: risks and benefits. Prog. Cardiovasc. Dis. 53:419–428.
27. Kitzman, D. W., B. Nicklas, W. E. Kraus, M. F. Lyles, J. Eggebeen, T. M. Morgan, et al. 2014. Skeletal muscle abnormalities and exercise intolerance in older patients with heart failure and preserved ejection fraction. Am. J. Physiol. Heart Circ. Physiol. 306:H1364–H1370.
28. Kubo, S. H., T. S. Rector, A. J. Bank, R. E. Williams, and S. M. Heifetz. 1991. Endothelium-dependent vasodilation is attenuated in patients with heart failure. Circulation 84:1589–1596.
29. LeJemtel, T. H., C. S. Maskin, D. Lucido, and B. J. Chadwick. 1986. Failure to augment maximal limb blood flow in response to one-leg versus two-leg exercise in patients with severe heart failure. Circulation 74:245–251.
30. Mancini, D. M., E. Coyle, A. Coggan, J. Beltz, N. Ferraro, S. Montain, et al. 1989. Contribution of intrinsic skeletal muscle changes to 31P NMR skeletal muscle metabolic abnormalities in patients with chronic heart failure. Circulation 80:1338–1346.
31. Mancini, D. M., G. Walter, N. Reichek, R. Lenkinski, K. K. Mccully, J. L. Mullen, et al. 1992. Contribution of skeletal-muscle atrophy to exercise intolerance and altered muscle metabolism in heart-failure. Circulation 85:1364–1373.
32. Massie, B. M., M. Conway, B. Rajagopalan, R. Yonge, S. Frostick, J. Ledingham, et al. 1988. Skeletal muscle metabolism during exercise under ischemic conditions in congestive heart failure. Evidence for abnormalities unrelated to blood flow. Circulation 78:320–326.
33. McCully, K. K., C. Halber, and J. D. Posner. 1994. Exercise- induced changes in oxygen saturation in the calf muscles of elderly subjects with peripheral vascular disease. J. Gerontol. 49:B128–B134.
34. McMurray, J. J., S. Adamopoulos, S. D. Anker, A. Auricchio, M. Bohm, K. Dickstein, et al. 2012. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur. J. Heart Fail. 14:803–869.
35. Mettauer, B., J. Zoll, H. Sanchez, E. Lampert, F. Ribera, V. Veksler, et al. 2001. Oxidative capacity of skeletal muscle in heart failure patients versus sedentary or active control subjects. J. Am. Coll. Cardiol. 38:947–954.
36. Mikus, C. R., L. J. Boyle, S. J. Borengasser, D. J. Oberlin, S. P. Naples, J. Fletcher, et al. 2013. Simvastatin impairs exercise training adaptations. J. Am. Coll. Cardiol. 62:709–714.
37. Minotti, J. R., E. C. Johnson, T. L. Hudson, G. Zuroske, G. Murata, E. Fukushima, et al. 1990. Skeletal muscle response to exercise training in congestive heart failure. J. Clin. Invest. 86:751–758.
38. Motobe, M., N. Murase, T. Osada, T. Homma, C. Ueda, T. Nagasawa, et al. 2004. Noninvasive monitoring of deterioration in skeletal muscle function with forearm cast immobilization and the prevention of deterioration. Dyn. Med. 3:2.
39. National Center for Health Statistics. 2011. Health, United States, 2010: with special feature on death and dying. National Center for Health Statistics, Hyattsville, MD.
40. O’Connor, C. M., D. J. Whellan, K. L. Lee, S. J. Keteyian, L. S. Cooper, S. J. Ellis, et al. 2009. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA 301:1439–1450.
41. Okita, K., K. Yonezawa, H. Nishijima, A. Hanada, M. Ohtsubo, T. Kohya, et al. 1998. Skeletal muscle metabolism limits exercise capacity in patients with chronic heart failure. Circulation 98:1886–1891.
42. Paiva, H., K. M. Thelen, R. Van Coster, J. Smet, B. De Paepe, K. M. Mattila, et al. 2005. High-dose statins and skeletal muscle metabolism in humans: a randomized, controlled trial. Clin. Pharmacol. Ther. 78:60–68.
43. Park, J. H., R. L. Brown, C. R. Park, M. Cohn, and B. Chance. 1988. Energy metabolism of the untrained muscle of elite runners as observed by 31P magnetic resonance spectroscopy: evidence suggesting a genetic endowment for endurance exercise. Proc. Natl Acad. Sci. USA 85:8780–8784.
44. Raina, A., T. Pickering, and D. Shimbo. 2006. Statin use in heart failure: a cause for concern? Am. Heart J. 152:39–49.
45. Roger, V. L., A. S. Go, D. M. Lloyd-Jones, E. J. Benjamin, J. D. Berry, and W. B. Borden, et al. 2012. Heart disease and stroke statistics — 2012 update: a report from the American Heart Association. Circulation 125:e2–e220.
46. Ryan, T. E., M. L. Erickson, J. T. Brizendine, H.-J. Young, and K. K. McCully. 2012. Noninvasive evaluation of skeletal muscle mitochondrial capacity with near-infrared spectroscopy: correcting for blood volume changes. J. Appl. Physiol. 113:175–183.
47. Ryan, T. E., W. M. Southern, J. T. Brizendine, and K. K. McCully. 2013a. Activity-induced changes in skeletal muscle metabolism measured with optical spectroscopy. Med. Sci. Sports Exerc. 45:2346–2352.
48. Ryan, T. E., W. M. Southern, M. A. Reynolds, and K. K. McCully. 2013b. A cross-validation of near-infrared spectroscopy measurements of skeletal muscle oxidative capacity with phosphorus magnetic resonance spectroscopy. J. Appl. Physiol. 115:1757–1766.
49. Ryan, T. E., P. Brophy, C. T. Lin, R. C. Hickner, and P. D. Neufer. 2014. Assessment of in vivo skeletal muscle mitochondrial respiratory capacity in humans by near- infrared spectroscopy: a comparison with in situ measurements. J. Physiol. 592:3231–3241.
50. Schaufelberger, M., B. O. Eriksson, G. Grimby, P. Held, and K. Swedberg. 1997. Skeletal muscle alterations in patients with chronic heart failure. Eur. Heart J. 18:971–980.
51. Schrepper, A., M. Schwarzer, M. Schöpe, P. A. Amorim, and T. Doenst. 2012. Biphasic response of skeletal muscle mitochondria to chronic cardiac pressure overload — Role of respiratory chain complex activity. J. Mol. Cell. Cardiol. 52:125–135.
52. Simonini, A., C. S. Long, G. A. Dudley, P. Yue, J. McElhinny, and B. M. Massie. 1996a. Heart failure in rats causes changes in skeletal muscle morphology and gene expression that are not explained by reduced activity. Circ. Res. 79:128–136.
53. Simonini, A., B. M. Massie, C. S. Long, M. Qi, and A. M. Samarel. 1996b. Alterations in skeletal muscle gene expression in the rat with chronic congestive heart failure. J. Mol. Cell. Cardiol. 28:1683–1691.
54. Sinzinger, H., and J. O’Grady. 2004. Professional athletes suffering from familial hypercholesterolaemia rarely tolerate statin treatment because of muscular problems. Br. J. Clin. Pharmacol. 57:525–528.
55. Southern, W. M., T. E. Ryan, M. A. Reynolds, and K. McCully. 2014. Reproducibility of near-infrared spectroscopy measurements of oxidative function and postexercise recovery kinetics in the medial gastrocnemius muscle. Appl. Physiol. Nutr. Metab. 39:521–529.
56. Sullivan, M. J., H. J. Green, and F. R. Cobb. 1990. Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure. Circulation 81:518–527.
57. Thompson, J. R., S. A. Swanson, G. P. Casale, J. M. Johanning, E. Papoutsi, P. Koutakis, et al. 2013. Gastrocnemius mitochondrial respiration: are there any differences between men and women? J. Surg. Res. 185:206–211.
58. Toth, M. J., M. S. Miller, K. A. Ward, and P. A. Ades. 2012. Skeletal muscle mitochondrial density, gene expression, and enzyme activities in human heart failure: minimal effects of the disease and resistance training. J. Appl. Physiol. 112:1864–1874.
59. Tousoulis, D., C. Antoniades, E. Bosinakou, M. Kotsopoulou, C. Pitsavos, C. Vlachopoulos, et al. 2005. Effects of atorvastatin on reactive hyperemia and inflammatory process in patients with congestive heart failure. Atherosclerosis 178:359–363.
60. Treasure, C. B., J. A. Vita, D. A. Cox, R. D. Fish, J. B. Gordon, G. H. Mudge, et al., et al. 1990. Endothelium- dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy. Circulation 81:772–779.
61. Van Beekvelt, M. C. P., W. N. J. M. Colier, R. A. Wevers, and B. G. M. Van Engelen. 2001. Performance of near- infrared spectroscopy in measuring local O2 consumption and blood flow in skeletal muscle. J. Appl. Physiol. 90:511–519.
62. Williams, A. D., S. Selig, D. L. Hare, A. Hayes, H. Krum, J. Patterson, et al. 2004. Reduced exercise tolerance in CHF may be related to factors other than impaired skeletal muscle oxidative capacity. J. Card Fail. 10:141–148.
63. Wisloff, U., A. Stoylen, J. P. Loennechen, M. Bruvold, O. Rognmo, P. M. Haram, et al. 2007. Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients: a randomized study. Circulation 115:3086–3094.
64. Zelis, R., J. Longhurst, R. J. Capone, and D. T. Mason. 1974. A comparison of regional blood flow and oxygen utilization during dynamic forearm exercise in normal subjects and patients with congestive heart failure. Circulation 50:137–143.